Literature DB >> 8086562

Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem.

V J Anttila1, P Ruutu, S Bondestam, S E Jansson, S Nordling, M Färkkilä, A Sivonen, M Castren, T Ruutu.   

Abstract

The occurrence of hepatosplenic candidiasis following prolonged neutropenic periods has emerged as a major problem for patients with leukemia. In order to evaluate the diagnostic value of various available procedures, we analyzed our findings regarding 26 leukemic patients with hepatosplenic candidiasis. A significantly increased level (> 50 mg/L) of serum C-reactive protein (S-CRP) was significantly more common than a daily fever (for which the mean temperature peak was > 37.5 degrees C) or raised levels of liver enzymes (serum alanine transferase, aspartate transferase, or alkaline phosphatase). Focal changes in the liver, spleen, or kidneys were detected in > 90% of the patients examined by computed tomography (CT) but in < 50% of those examined by ultrasonography. Seventeen diagnoses were based on the findings from microscopy of samples obtained invasively, whereas a positive fungal culture was the basis of the diagnosis for only five patients. In conclusion, monitoring the S-CRP level after a patient's recovery from neutropenia is useful in that its elevation is cause for early suspicion of hepatosplenic candidiasis. In detection of the hepatosplenic foci, CT is superior to ultrasonography. For establishing the specific diagnosis, aggressive collection of samples for microscopy is essential.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086562     DOI: 10.1093/clinids/18.6.979

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Hepatosplenic candidiasis after neutropenic phase of acute leukaemia.

Authors:  M Colović; V Lazarević; R Colović; G Janković; N Suvajdzić; A Bogdanović; J Bila
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia.

Authors:  D G Lee; J H Choi; Y J Kim; S Lee; C K Min; D W Kim; J W Lee; W S Min; W S Shin; C C Kim
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 3.  Therapy for fungal infections in leukemia.

Authors:  R E Segal; G Y Minamoto
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

4.  Candidal liver abscesses and cholecystitis in a 37-year-old patient without underlying malignancy.

Authors:  Chung-Hsu Lai; Hsin-Pai Chen; Te-Li Chen; Chang-Phone Fung; Cheng-Yi Liu; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

5.  PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.

Authors:  G Morace; L Pagano; M Sanguinetti; B Posteraro; L Mele; F Equitani; G D'Amore; G Leone; G Fadda
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis.

Authors:  V J Anttila; M Färkkilä; S E Jansson; M Taavitsainen; S S Kaukoranta-Tolvanen; S Nordling; P Koukila-Kähkölä; T Ruutu; P Ruutu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

Review 7.  PCR-based diagnosis of human fungal infections.

Authors:  Prasanna D Khot; David N Fredricks
Journal:  Expert Rev Anti Infect Ther       Date:  2009-12       Impact factor: 5.091

8.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 9.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.

Authors:  Malgorzata Mikulska; Thierry Calandra; Maurizio Sanguinetti; Daniel Poulain; Claudio Viscoli
Journal:  Crit Care       Date:  2010-12-08       Impact factor: 9.097

10.  Antifungal Activity of Bee Venom and Sweet Bee Venom against Clinically Isolated Candida albicans.

Authors:  Seung-Bae Lee
Journal:  J Pharmacopuncture       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.